Loading...

DICE Therapeutics, Inc. Peer Comparison

Metric Value Ranking
Market Cap $2.3 Billion 11/19 KRTX
$12.6B
PCVX
$10.5B
ASND
$8.6B
NUVL
$5.5B
CYTK
$5.4B
ACLX
$3.5B
CRNX
$3.3B
MLTX
$2.7B
KDNY
$2.7B
EWTX
$2.4B
DICE
$2.3B
IMCR
$1.5B
DYN
$1.4B
VRDN
$1.3B
DAWN
$1.2B
TERN
$344.9M
PLRX
$185.0M
VTYX
$120.9M
ABOS
$87.1M
Gross Margin 0% 8/19 CYTK
100%
VRDN
100%
ACLX
100%
IMCR
99%
ASND
92%
DAWN
92%
KDNY
57%
DICE
0%
DYN
0%
CRNX
0%
KRTX
0%
PLRX
0%
PCVX
0%
EWTX
0%
TERN
0%
NUVL
0%
ABOS
0%
VTYX
0%
MLTX
0%
Profit Margin 0% 3/19 DAWN
100%
IMCR
11%
DICE
0%
DYN
0%
CRNX
0%
KRTX
0%
PLRX
0%
PCVX
0%
EWTX
0%
TERN
0%
NUVL
0%
ABOS
0%
VTYX
0%
MLTX
0%
ASND
-22%
ACLX
-99%
CYTK
-100%
KDNY
-100%
VRDN
-100%
EBITDA margin -100% 4/19 DAWN
148%
IMCR
-11%
ASND
-22%
DICE
-100%
DYN
-100%
CRNX
-100%
KRTX
-100%
PLRX
-100%
PCVX
-100%
EWTX
-100%
TERN
-100%
NUVL
-100%
ABOS
-100%
VTYX
-100%
MLTX
-100%
ACLX
-129%
KDNY
-6934%
CYTK
-29859%
VRDN
-97070%
Quarterly Revenue $0 8/19 ASND
$191.1M
IMCR
$80.2M
ACLX
$26.0M
DAWN
$20.1M
KDNY
$1.0M
CYTK
$463,000
VRDN
$86,000
DICE
$0
DYN
$0
CRNX
$0
KRTX
$0
PLRX
$0
PCVX
$0
EWTX
$0
TERN
$0
NUVL
$0
ABOS
$0
VTYX
$0
MLTX
$0
Quarterly Earnings -$34.8 Million 7/19 DAWN
$37.0M
IMCR
$8.7M
TERN
-$21.9M
ACLX
-$25.9M
ABOS
-$29.8M
EWTX
-$34.1M
DICE
-$34.8M
VTYX
-$35.2M
MLTX
-$35.9M
ASND
-$42.3M
PLRX
-$57.8M
KDNY
-$66.9M
VRDN
-$76.7M
CRNX
-$76.8M
NUVL
-$84.3M
DYN
-$97.1M
PCVX
-$103.1M
KRTX
-$113.8M
CYTK
-$160.5M
Quarterly Free Cash Flow -$30.4 Million 9/19 ACLX
$28.4M
IMCR
$20.3M
DAWN
-$5.0M
TERN
-$16.5M
PCVX
-$21.7M
ABOS
-$24.6M
MLTX
-$25.4M
EWTX
-$27.9M
DICE
-$30.4M
PLRX
-$33.2M
VTYX
-$35.5M
NUVL
-$45.8M
KDNY
-$61.8M
CRNX
-$63.4M
VRDN
-$68.0M
DYN
-$74.9M
ASND
-$96.2M
CYTK
-$104.0M
KRTX
-$111.9M
Trailing 4 Quarters Revenue $0 13/19 ASND
$399.8M
IMCR
$331.8M
ACLX
$155.8M
DAWN
$28.8M
PLRX
$4.8M
DYN
$3.8M
KDNY
$3.3M
CYTK
$3.2M
CRNX
$1.0M
KRTX
$654,000
VRDN
$302,000
MLTX
$19,738
DICE
$0
PCVX
$0
EWTX
$0
TERN
$0
NUVL
$0
ABOS
$0
VTYX
$0
Trailing 4 Quarters Earnings -$97.7 Million 6/19 ASND
$191.1M
IMCR
$80.2M
ACLX
$26.0M
DAWN
$20.1M
KDNY
$1.0M
CYTK
$463,000
VRDN
$86,000
DICE
-$0
DYN
-$0
CRNX
-$0
KRTX
-$0
PLRX
-$0
PCVX
-$0
EWTX
-$0
TERN
-$0
NUVL
-$0
ABOS
-$0
VTYX
-$0
MLTX
-$0
Quarterly Earnings Growth -62% 15/19 IMCR
359%
DAWN
180%
ASND
56%
VTYX
35%
ACLX
34%
TERN
26%
PCVX
-11%
CYTK
-24%
EWTX
-33%
CRNX
-34%
PLRX
-39%
KRTX
-49%
DYN
-61%
VRDN
-61%
DICE
-62%
KDNY
-78%
ABOS
-130%
NUVL
-151%
MLTX
-281%
Annual Earnings Growth -26% 9/19 ACLX
63%
VTYX
51%
DAWN
50%
ASND
34%
TERN
-6%
CYTK
-12%
DYN
-16%
VRDN
-21%
DICE
-26%
PLRX
-28%
CRNX
-32%
IMCR
-33%
KRTX
-37%
EWTX
-38%
PCVX
-71%
ABOS
-71%
KDNY
-85%
NUVL
-85%
MLTX
-110161%
Quarterly Revenue Growth 0% 6/19 ACLX
74%
IMCR
56%
ASND
26%
CYTK
22%
VRDN
19%
DICE
0%
DYN
0%
PLRX
0%
PCVX
0%
KDNY
0%
EWTX
0%
TERN
0%
NUVL
0%
DAWN
0%
ABOS
0%
VTYX
0%
MLTX
0%
CRNX
-100%
KRTX
-100%
Annual Revenue Growth 0% 7/19 PLRX
551%
ACLX
169%
IMCR
70%
ASND
29%
CYTK
8%
VRDN
5%
DICE
0%
DYN
0%
PCVX
0%
KDNY
0%
EWTX
0%
TERN
0%
NUVL
0%
DAWN
0%
ABOS
0%
VTYX
0%
MLTX
0%
CRNX
-69%
KRTX
-88%
Cash On Hand $73.5 Million 15/19 PCVX
$1.1B
ASND
$614.9M
IMCR
$537.8M
DYN
$532.2M
DAWN
$422.8M
MLTX
$375.7M
NUVL
$369.2M
CRNX
$317.3M
TERN
$270.1M
VRDN
$200.3M
KRTX
$185.8M
ACLX
$161.8M
KDNY
$127.1M
PLRX
$79.6M
DICE
$73.5M
VTYX
$61.8M
CYTK
$46.9M
EWTX
$44.8M
ABOS
$33.2M
Short Term Debt $1.5 Million 10/19 ASND
$540.1M
IMCR
$49.3M
CYTK
$30.4M
ACLX
$18.1M
PCVX
$9.6M
CRNX
$7.4M
DYN
$4.8M
KDNY
$4.3M
KRTX
$2.8M
DICE
$1.5M
MLTX
$1.4M
VTYX
$1.0M
EWTX
$992,000
PLRX
$322,000
TERN
$272,000
ABOS
$129,000
DAWN
$77,000
VRDN
-$0
NUVL
-$0
Long Term Debt $11.0 Million 13/19 CYTK
$759.3M
ASND
$401.2M
PLRX
$59.9M
ACLX
$47.2M
CRNX
$45.1M
IMCR
$41.3M
ABOS
$29.9M
KDNY
$29.7M
VRDN
$20.5M
DYN
$20.0M
PCVX
$18.3M
KRTX
$13.8M
DICE
$11.0M
VTYX
$10.0M
EWTX
$3.4M
DAWN
$2.5M
MLTX
$1.9M
TERN
$1.0M
NUVL
$0
PE -1.00 1/19 DICE
-1.00
DYN
-1.00
CYTK
-1.00
ASND
-1.00
CRNX
-1.00
KRTX
-1.00
PLRX
-1.00
PCVX
-1.00
KDNY
-1.00
EWTX
-1.00
VRDN
-1.00
TERN
-1.00
NUVL
-1.00
DAWN
-1.00
IMCR
-1.00
ABOS
-1.00
ACLX
-1.00
VTYX
-1.00
MLTX
-1.00
PS -1.00 13/19 MLTX
138058.12
KRTX
19264.95
VRDN
4301.62
CRNX
3142.72
CYTK
1692.30
KDNY
808.88
DYN
373.70
DAWN
42.90
PLRX
38.22
ACLX
22.64
ASND
19.63
IMCR
4.46
DICE
-1.00
PCVX
-1.00
EWTX
-1.00
TERN
-1.00
NUVL
-1.00
ABOS
-1.00
VTYX
-1.00
PB 4.37 7/19 KRTX
10.05
KDNY
7.58
ACLX
7.30
MLTX
5.50
NUVL
4.94
EWTX
4.92
DICE
4.37
CRNX
3.92
IMCR
3.92
PCVX
3.06
DAWN
2.23
DYN
2.01
VRDN
1.84
TERN
0.95
PLRX
0.53
VTYX
0.43
ABOS
0.40
CYTK
0.00
ASND
0.00
PC 30.91 4/19 CYTK
116.18
KRTX
67.80
EWTX
53.66
DICE
30.91
ACLX
21.79
KDNY
21.30
NUVL
15.00
ASND
14.02
CRNX
10.29
PCVX
9.97
MLTX
7.25
VRDN
6.49
DAWN
2.92
IMCR
2.75
DYN
2.66
ABOS
2.63
PLRX
2.32
VTYX
1.96
TERN
1.28
Liabilities to Equity 0.06 12/19 IMCR
1.87
ACLX
0.58
KDNY
0.37
PLRX
0.29
ABOS
0.23
CRNX
0.13
DYN
0.09
VRDN
0.09
DAWN
0.08
VTYX
0.08
KRTX
0.07
DICE
0.06
NUVL
0.06
EWTX
0.05
MLTX
0.05
PCVX
0.04
TERN
0.04
CYTK
0.00
ASND
0.00
ROA -0.18 5/19 IMCR
-5%
ACLX
-5%
PCVX
-14%
DAWN
-15%
DICE
-18%
NUVL
-19%
TERN
-23%
EWTX
-24%
CRNX
-30%
ABOS
-31%
KRTX
-32%
VRDN
-33%
ASND
-35%
VTYX
-35%
DYN
-39%
CYTK
-40%
PLRX
-47%
KDNY
-50%
MLTX
-8478%
ROE -0.19 7/19 CYTK
4143%
ASND
394%
ACLX
-8%
IMCR
-14%
PCVX
-15%
DAWN
-16%
DICE
-19%
NUVL
-20%
TERN
-24%
EWTX
-25%
CRNX
-33%
KRTX
-34%
VRDN
-36%
ABOS
-38%
VTYX
-38%
DYN
-42%
PLRX
-61%
KDNY
-69%
MLTX
-8999%
Current Ratio 17.42 6/19 TERN
27.48
PCVX
25.05
EWTX
22.82
MLTX
22.82
NUVL
17.55
DICE
17.42
KRTX
16.30
VTYX
13.49
DAWN
13.25
DYN
12.15
VRDN
11.99
CRNX
8.98
ABOS
5.36
PLRX
4.46
KDNY
3.71
ACLX
2.71
IMCR
1.53
CYTK
0.99
ASND
0.92
Quick Ratio 16.71 5/19 DICE
-1.00
DYN
-1.00
CYTK
-1.00
ASND
-1.00
CRNX
-1.00
KRTX
-1.00
PLRX
-1.00
PCVX
-1.00
KDNY
-1.00
EWTX
-1.00
VRDN
-1.00
TERN
-1.00
NUVL
-1.00
DAWN
-1.00
IMCR
-1.00
ABOS
-1.00
ACLX
-1.00
VTYX
-1.00
MLTX
-1.00
Long Term Debt to Equity 0.02 10/19 PLRX}
0.17
ABOS}
0.14
IMCR}
0.11
ACLX}
0.10
KDNY}
0.08
CRNX}
0.05
VTYX}
0.04
DYN}
0.03
VRDN}
0.03
DICE}
0.02
KRTX}
0.01
PCVX}
0.01
EWTX}
0.01
TERN}
0.00
NUVL}
0.00
DAWN}
0.00
MLTX}
0.00
ASND}
-3.45
CYTK}
-54.58
Debt to Equity 0.02 10/19 IMCR
0.24
PLRX
0.17
ABOS
0.14
ACLX
0.14
KDNY
0.10
CRNX
0.06
DYN
0.04
VTYX
0.04
VRDN
0.03
DICE
0.02
KRTX
0.01
PCVX
0.01
EWTX
0.01
MLTX
0.01
TERN
0.00
NUVL
0.00
DAWN
0.00
ASND
-8.10
CYTK
-48.51
Burn Rate 2.06 11/19 IMCR
102.61
TERN
12.25
MLTX
10.33
PCVX
9.88
DYN
5.37
ACLX
5.01
NUVL
4.38
CRNX
3.94
ASND
3.11
VRDN
2.58
DICE
2.06
KDNY
1.84
VTYX
1.72
KRTX
1.61
PLRX
1.32
EWTX
1.30
ABOS
1.07
CYTK
0.24
DAWN
-11.45
Cash to Cap 0.03 16/19 TERN
0.78
VTYX
0.51
PLRX
0.43
DYN
0.38
ABOS
0.38
IMCR
0.36
DAWN
0.34
VRDN
0.15
MLTX
0.14
CRNX
0.10
PCVX
0.10
ASND
0.07
NUVL
0.07
KDNY
0.05
ACLX
0.05
DICE
0.03
EWTX
0.02
CYTK
0.01
KRTX
0.01
CCR 0.87 7/19 IMCR
2.32
ASND
2.28
VTYX
1.01
KRTX
0.98
KDNY
0.92
VRDN
0.89
DICE
0.87
ABOS
0.83
CRNX
0.82
EWTX
0.82
DYN
0.77
TERN
0.75
MLTX
0.71
CYTK
0.65
PLRX
0.57
NUVL
0.54
PCVX
0.21
DAWN
-0.13
ACLX
-1.10
EV to EBITDA -1.00 2/19 DAWN}
27.54
DICE}
-1.00
PCVX}
-1.00
EWTX}
-1.00
TERN}
-1.00
NUVL}
-1.00
ABOS}
-1.00
VTYX}
-1.00
PLRX}
-2.67
DYN}
-8.63
VRDN}
-13.41
CRNX}
-34.18
KDNY}
-37.41
CYTK}
-43.95
MLTX}
-65.31
KRTX}
-96.25
ACLX}
-102.06
IMCR}
-121.57
ASND}
-257.89
EV to Revenue -1.00 13/19 MLTX
119197.26
KRTX
19006.33
VRDN
3706.27
CRNX
2887.93
CYTK
1887.39
KDNY
781.05
DYN
239.77
PLRX
34.21
DAWN
28.32
ASND
24.44
ACLX
22.02
IMCR
3.12
DICE
-1.00
PCVX
-1.00
EWTX
-1.00
TERN
-1.00
NUVL
-1.00
ABOS
-1.00
VTYX
-1.00